nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Tapentadol—Angioedema—Prednisolone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Tapentadol—Breast disorder—Methotrexate—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Tapentadol—Vertigo—Prednisolone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Tapentadol—Syncope—Prednisolone—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Tapentadol—Eye disorder—Betamethasone—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Tapentadol—Eye disorder—Dexamethasone—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Tapentadol—Loss of consciousness—Prednisolone—psoriatic arthritis	0.0029	0.0029	CcSEcCtD
Tapentadol—Angiopathy—Dexamethasone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Tapentadol—Angiopathy—Betamethasone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Tapentadol—Convulsion—Prednisolone—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Tapentadol—Bradycardia—Prednisone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Tapentadol—Angioedema—Triamcinolone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Tapentadol—Angioedema—Methylprednisolone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Tapentadol—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Tapentadol—Hallucination—Prednisone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Tapentadol—Vertigo—Triamcinolone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Tapentadol—Syncope—Triamcinolone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Tapentadol—Vertigo—Methylprednisolone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Tapentadol—Syncope—Methylprednisolone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Tapentadol—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Tapentadol—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Tapentadol—Oedema—Prednisolone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Tapentadol—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Tapentadol—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00266	0.00266	CcSEcCtD
Tapentadol—Shock—Prednisolone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Tapentadol—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Tapentadol—Cough—Triamcinolone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Tapentadol—Convulsion—Triamcinolone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Tapentadol—Tachycardia—Prednisolone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Tapentadol—Convulsion—Methylprednisolone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Tapentadol—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Tapentadol—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Tapentadol—Eye disorder—Prednisone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Tapentadol—Anxiety—Methylprednisolone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Tapentadol—Infestation NOS—Methotrexate—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Tapentadol—Infestation—Methotrexate—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Tapentadol—Depression—Methotrexate—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Tapentadol—Dry mouth—Triamcinolone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Tapentadol—Angioedema—Dexamethasone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Tapentadol—Angioedema—Betamethasone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Tapentadol—Angiopathy—Prednisone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Tapentadol—Confusional state—Methylprednisolone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Tapentadol—Immune system disorder—Prednisone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Tapentadol—Oedema—Triamcinolone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Tapentadol—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Tapentadol—Vertigo—Dexamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Tapentadol—Vertigo—Betamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Tapentadol—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Tapentadol—Syncope—Dexamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Tapentadol—Syncope—Betamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Tapentadol—Infection—Triamcinolone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Tapentadol—Infection—Methylprednisolone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Tapentadol—Shock—Triamcinolone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Tapentadol—Insomnia—Prednisolone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Tapentadol—Shock—Methylprednisolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Tapentadol—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Tapentadol—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Tapentadol—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Tapentadol—Paraesthesia—Prednisolone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Tapentadol—Tachycardia—Triamcinolone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Tapentadol—Mental disorder—Prednisone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Tapentadol—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Tapentadol—Skin disorder—Methylprednisolone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Tapentadol—Malnutrition—Prednisone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Tapentadol—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Tapentadol—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Tapentadol—Convulsion—Betamethasone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Tapentadol—Convulsion—Dexamethasone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Tapentadol—Anxiety—Betamethasone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Tapentadol—Anxiety—Dexamethasone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Tapentadol—Hypotension—Methylprednisolone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Tapentadol—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Tapentadol—Vision blurred—Prednisone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Tapentadol—Urethral disorder—Methotrexate—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Tapentadol—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Tapentadol—Oedema—Dexamethasone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Tapentadol—Oedema—Betamethasone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Tapentadol—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Tapentadol—Insomnia—Triamcinolone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Tapentadol—Insomnia—Methylprednisolone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Tapentadol—Infection—Betamethasone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Tapentadol—Infection—Dexamethasone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Tapentadol—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Tapentadol—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Tapentadol—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Tapentadol—Visual impairment—Methotrexate—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Tapentadol—Shock—Dexamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Tapentadol—Shock—Betamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Tapentadol—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Tapentadol—Nervous system disorder—Betamethasone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Tapentadol—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Tapentadol—Agitation—Prednisone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Tapentadol—Tachycardia—Dexamethasone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Tapentadol—Tachycardia—Betamethasone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Tapentadol—Angioedema—Prednisone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Tapentadol—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Tapentadol—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Tapentadol—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Tapentadol—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Tapentadol—Vertigo—Prednisone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Tapentadol—Eye disorder—Methotrexate—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Tapentadol—Syncope—Prednisone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Tapentadol—Urticaria—Prednisolone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Tapentadol—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Tapentadol—Fatigue—Triamcinolone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Tapentadol—Fatigue—Methylprednisolone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Tapentadol—Loss of consciousness—Prednisone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Tapentadol—Hypotension—Dexamethasone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Tapentadol—Hypotension—Betamethasone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Tapentadol—Angiopathy—Methotrexate—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Tapentadol—Immune system disorder—Methotrexate—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Tapentadol—Convulsion—Prednisone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Tapentadol—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Tapentadol—Chills—Methotrexate—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Tapentadol—Arthralgia—Prednisone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Tapentadol—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Tapentadol—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Tapentadol—Anxiety—Prednisone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Tapentadol—Insomnia—Dexamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Tapentadol—Insomnia—Betamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Tapentadol—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Tapentadol—Paraesthesia—Betamethasone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Tapentadol—Mental disorder—Methotrexate—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Tapentadol—Malnutrition—Methotrexate—psoriatic arthritis	0.002	0.002	CcSEcCtD
Tapentadol—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Tapentadol—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Tapentadol—Dyspepsia—Betamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Tapentadol—Urticaria—Triamcinolone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Tapentadol—Urticaria—Methylprednisolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Tapentadol—Oedema—Prednisone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Tapentadol—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Tapentadol—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Tapentadol—Decreased appetite—Betamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Tapentadol—Infection—Prednisone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Tapentadol—Fatigue—Dexamethasone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Tapentadol—Fatigue—Betamethasone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Tapentadol—Shock—Prednisone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Tapentadol—Nervous system disorder—Prednisone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Tapentadol—Tachycardia—Prednisone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Tapentadol—Skin disorder—Prednisone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Tapentadol—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Tapentadol—Vision blurred—Methotrexate—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Tapentadol—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Tapentadol—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Tapentadol—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Tapentadol—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Tapentadol—Vertigo—Methotrexate—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Tapentadol—Urticaria—Dexamethasone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Tapentadol—Urticaria—Betamethasone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Tapentadol—Dizziness—Prednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Tapentadol—Asthenia—Triamcinolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Tapentadol—Asthenia—Methylprednisolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Tapentadol—Insomnia—Prednisone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Tapentadol—Paraesthesia—Prednisone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Tapentadol—Pruritus—Triamcinolone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Tapentadol—Cough—Methotrexate—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Tapentadol—Pruritus—Methylprednisolone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Tapentadol—Convulsion—Methotrexate—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Tapentadol—Dyspepsia—Prednisone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Tapentadol—Arthralgia—Methotrexate—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Tapentadol—Decreased appetite—Prednisone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Tapentadol—Rash—Prednisolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Tapentadol—Dermatitis—Prednisolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Tapentadol—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Tapentadol—Fatigue—Prednisone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Tapentadol—Headache—Prednisolone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Tapentadol—Constipation—Prednisone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Tapentadol—Confusional state—Methotrexate—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Tapentadol—Dizziness—Triamcinolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Tapentadol—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Tapentadol—Dizziness—Methylprednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Tapentadol—Infection—Methotrexate—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Tapentadol—Feeling abnormal—Prednisone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Tapentadol—Asthenia—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Tapentadol—Asthenia—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Tapentadol—Nervous system disorder—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Tapentadol—Nausea—Prednisolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Tapentadol—Pruritus—Betamethasone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Tapentadol—Pruritus—Dexamethasone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Tapentadol—Skin disorder—Methotrexate—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Tapentadol—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Tapentadol—Vomiting—Triamcinolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Tapentadol—Vomiting—Methylprednisolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Tapentadol—Rash—Triamcinolone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Tapentadol—Dermatitis—Triamcinolone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Tapentadol—Rash—Methylprednisolone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Tapentadol—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Tapentadol—Urticaria—Prednisone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Tapentadol—Headache—Triamcinolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Tapentadol—Headache—Methylprednisolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Tapentadol—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Tapentadol—Diarrhoea—Betamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Tapentadol—Hypotension—Methotrexate—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Tapentadol—Dizziness—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Tapentadol—Dizziness—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Tapentadol—Insomnia—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Tapentadol—Nausea—Triamcinolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Tapentadol—Paraesthesia—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Tapentadol—Nausea—Methylprednisolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Tapentadol—Dyspnoea—Methotrexate—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Tapentadol—Somnolence—Methotrexate—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Tapentadol—Hypersensitivity—Prednisone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Tapentadol—Dyspepsia—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Tapentadol—Vomiting—Betamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Tapentadol—Vomiting—Dexamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Tapentadol—Decreased appetite—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Tapentadol—Rash—Betamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Tapentadol—Rash—Dexamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Tapentadol—Dermatitis—Betamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Tapentadol—Dermatitis—Dexamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Tapentadol—Fatigue—Methotrexate—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Tapentadol—Headache—Dexamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Tapentadol—Headache—Betamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Tapentadol—Asthenia—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Tapentadol—Pruritus—Prednisone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Tapentadol—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Tapentadol—Diarrhoea—Prednisone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Tapentadol—Nausea—Betamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Tapentadol—Nausea—Dexamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Tapentadol—Urticaria—Methotrexate—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Tapentadol—Dizziness—Prednisone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Tapentadol—Vomiting—Prednisone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Tapentadol—Rash—Prednisone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Tapentadol—Dermatitis—Prednisone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Tapentadol—Headache—Prednisone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Tapentadol—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Tapentadol—Asthenia—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Tapentadol—Nausea—Prednisone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Tapentadol—Pruritus—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Tapentadol—Diarrhoea—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Tapentadol—Dizziness—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Tapentadol—Vomiting—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Tapentadol—Rash—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Tapentadol—Dermatitis—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Tapentadol—Headache—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Tapentadol—Nausea—Methotrexate—psoriatic arthritis	0.000972	0.000972	CcSEcCtD
